5-methylcytosine has been researched along with Testicular Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cen, X; Ou, J; Shen, Y; Wang, B; Wang, L | 1 |
| Amouroux, R; Benešová, M; Hajkova, P; Hejnar, J; Hron, T; Klézl, P; Kučerová, D; Szabó, A; Trejbalová, K; Vernerová, Z | 1 |
2 other study(ies) available for 5-methylcytosine and Testicular Neoplasms
| Article | Year |
|---|---|
Loss of 5-hydroxymethylcytosine as a Poor Prognostic Factor for Primary Testicular Diffuse Large B-cell Lymphoma.
Topics: 5-Methylcytosine; Aged; Biomarkers, Tumor; Humans; Immunohistochemistry; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Testicular Neoplasms; Testis | 2022 |
Overexpression of TET dioxygenases in seminomas associates with low levels of DNA methylation and hydroxymethylation.
Topics: 5-Methylcytosine; Adult; Dioxygenases; DNA Methylation; DNA-Binding Proteins; Gene Expression Regulation, Neoplastic; Humans; Male; Mixed Function Oxygenases; Proto-Oncogene Proteins; Seminoma; Testicular Neoplasms; Testis; Up-Regulation | 2017 |